DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the VASA DENTICITY LIMITED (DENTALKART) share price today?

VASA DENTICITY LIMITED (DENTALKART) is trading at ₹432.3 on the NSE, up 6.78% on the day. Source: DocStoX.

What is the PE ratio of VASA DENTICITY LIMITED?

VASA DENTICITY LIMITED has a price-to-earnings (PE) ratio of 42.0 in the Healthcare sector.

What is the market capitalisation of VASA DENTICITY LIMITED?

VASA DENTICITY LIMITED has a market capitalisation of approximately ₹0 crore.

VASA DENTICITY LIMITED

DENTALKART·NSE·Healthcare

₹432.30▲ +27.45 (+6.78%)

Healthcare · Medical Equipment

A steady, established business

Day₹409.85

₹436.00

52W₹323

₹69030%

Open

₹409.85

High

₹436.00

Low

₹409.85

Prev Close

₹404.85

Volume

32.0K

VWAP

₹425.96

Snapshot

Key fundamentals

Market Cap

₹0 Cr

P/E Ratio

42.05Expensive

P/B Ratio

3.82

EPS

₹10.28

Book Value

₹100.33

ROE

7.02%Weak

ROCE

22.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.00Low

Face Value

₹10.00

52W High

₹690.00

52W Low

₹322.50

Sector

Healthcare

Industry

Medical Equipment

Avoid

None moatHigh uncertainty

Fair value estimate

₹113

▼ 73.9%downside

Trading at ₹432 — 74% above our estimate

BearFair valueBull

₹96₹113₹152

/100

Business quality — Watch the fundamentals

Growth 10Profitability 19Efficiency 35Valuation 60

Plain English

Our view

A steady, established business
Virtually debt-free balance sheet
Weak returns on equity (7%)

Strengths

Virtually debt-free balance sheet
Capital is working hard (ROCE 22%)
Promoters hold a controlling stake

Risks

Weak returns on equity (7%)
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

13% ROE fading to 12% over ~3 yrs, on ₹100 book

₹102

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹152

Analyst target

No analyst coverage

—

Blended fair value₹113

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Capital is working hard (ROCE 22%)
Promoters hold a controlling stake

Bear case

Weak returns on equity (7%)
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

42.0Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

7.0%Weak

Above 15% is considered healthy for Indian equities

ROCE

22.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.00Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

—

P/B

3.82

EPS

₹10.28

Div Yield

—

What changed

Recent changes

Foreign investors-0.6% stake last quarter
Domestic institutions+0.8% stake last quarter
Promoters-0.56% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 42.0×

Growth

Strong

+31% rev CAGR

Profitability

Modest

7.0% ROE

Financial health

Rock solid

D/E 0.00

Momentum

N/A

No technicals

Today

Trading activity

Delivery %67.2%

Turnover₹136.31L Cr

Trades95

VWAP₹425.96

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+31.4%

+47.5%

10Y

—

Profit

+8.6%

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Company is almost debt free.
Debtor days have improved from 20.0 to 15.2 days.

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding has decreased over last quarter: -0.56%
Earnings include an other income of Rs.4.65 Cr.
Working capital days have increased from 123 days to 189 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters trimmed their stake by 0.56 pts; foreign investors sold 0.57 pts; domestic institutions added 0.79 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

60%

Promoter

Promoters

60.2%-0.56

Public

31.2%+0.35

FII / FPI

6.9%-0.57

DII

1.7%+0.79

Total shareholders

2,495-451 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter60.19%

FII6.93%

DII1.66%

Public31.23%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2016, Vasa Denticity Limited is in the business of marketing and distribution of a comprehensive portfolio of Dental Products.[1]